Koers Merrimack Pharmaceuticals Inc Nasdaq
Aandelen
US5903281005
Biotechnologie & Medisch Onderzoek
Omzet 2022 | - | Omzet 2023 | - | Marktkapitalisatie | 192 mln. 176 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -1 mln. -917K | Nettowinst (verlies) 2023 | -1 mln. -917K | EV/omzet 2022 | - |
Nettoliquiditeiten 2022 | 19,44 mln. 17,83 mln. | Nettoliquiditeiten 2023 | 18,88 mln. 17,31 mln. | EV/omzet 2023 | - |
K/w-verhouding 2022 |
-100
x | K/w-verhouding 2023 |
-162
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 98,81% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ulrik Nielsen
FOU | Founder | 52 | 01-01-93 |
Gary Crocker
CEO | Chief Executive Officer | 72 | 01-01-04 |
Investor Relations Contact | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Gary Crocker
CEO | Chief Executive Officer | 72 | 01-01-04 |
Director/Board Member | 46 | 19-09-19 | |
Ulrik Nielsen
FOU | Founder | 52 | 01-01-93 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+25,83% | 46,56 mld. | |
+45,38% | 41,67 mld. | |
+0,69% | 41,16 mld. | |
+30,52% | 32,4 mld. | |
+22,30% | 28,18 mld. | |
-6,35% | 28,1 mld. | |
+49,25% | 14,52 mld. | |
+49,18% | 13,74 mld. | |
+3,45% | 12,17 mld. |